206 related articles for article (PubMed ID: 21292366)
1. Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population.
O'Seaghdha CM; Hwang SJ; Bhavsar NA; Köttgen A; Coresh J; Astor BC; Fox CS
Am J Kidney Dis; 2011 Jun; 57(6):841-9. PubMed ID: 21292366
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
Bhavsar NA; Köttgen A; Coresh J; Astor BC
Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
[TBL] [Abstract][Full Text] [Related]
3. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.
Foster MC; Hwang SJ; Larson MG; Lichtman JH; Parikh NI; Vasan RS; Levy D; Fox CS
Am J Kidney Dis; 2008 Jul; 52(1):39-48. PubMed ID: 18440684
[TBL] [Abstract][Full Text] [Related]
4. Urine Biomarkers of Kidney Tubule Health and Risk of Incident CKD in Persons Without Diabetes: The ARIC, MESA, and REGARDS Studies.
Amatruda JG; Katz R; Rebholz CM; Sarnak MJ; Gutierrez OM; Schrauben SJ; Greenberg JH; Coresh J; Cushman M; Waikar S; Parikh CR; Schelling JR; Jogalekar MP; Bonventre JV; Vasan RS; Kimmel PL; Ix JH; Shlipak MG;
Kidney Med; 2024 Jun; 6(6):100834. PubMed ID: 38826568
[TBL] [Abstract][Full Text] [Related]
5. Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study.
Astor BC; Köttgen A; Hwang SJ; Bhavsar N; Fox CS; Coresh J
Am J Nephrol; 2011; 34(4):291-7. PubMed ID: 21829008
[TBL] [Abstract][Full Text] [Related]
6. Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
Sumida K; Kwak L; Grams ME; Yamagata K; Punjabi NM; Kovesdy CP; Coresh J; Matsushita K
Am J Kidney Dis; 2017 Nov; 70(5):675-685. PubMed ID: 28754455
[TBL] [Abstract][Full Text] [Related]
7. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.
Matsushita K; Selvin E; Bash LD; Astor BC; Coresh J
Am J Kidney Dis; 2010 Apr; 55(4):648-59. PubMed ID: 20189275
[TBL] [Abstract][Full Text] [Related]
8. Low ankle-brachial index and the development of rapid estimated GFR decline and CKD.
Foster MC; Ghuman N; Hwang SJ; Murabito JM; Fox CS
Am J Kidney Dis; 2013 Feb; 61(2):204-10. PubMed ID: 22901770
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
Isakova T; Craven TE; Lee J; Scialla JJ; Xie H; Wahl P; Marcovina SM; Byington RP; Wolf M
Clin J Am Soc Nephrol; 2015 Jan; 10(1):29-38. PubMed ID: 25343949
[TBL] [Abstract][Full Text] [Related]
10. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
11. Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA).
Shastri S; Katz R; Shlipak MG; Kestenbaum B; Peralta CA; Kramer H; Jacobs DR; de Boer IH; Cushman M; Siscovick D; Sarnak MJ
Am J Kidney Dis; 2011 Jun; 57(6):832-40. PubMed ID: 21296473
[TBL] [Abstract][Full Text] [Related]
12. Association Between Midlife Physical Activity and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
Parvathaneni K; Surapaneni A; Ballew SH; Palta P; Rebholz CM; Selvin E; Coresh J; Grams ME
Am J Kidney Dis; 2021 Jan; 77(1):74-81. PubMed ID: 32971191
[TBL] [Abstract][Full Text] [Related]
13. Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study.
Daya N; Voskertchian A; Schneider ALC; Ballew S; McAdams DeMarco M; Coresh J; Appel LJ; Selvin E; Grams ME
Am J Kidney Dis; 2016 Feb; 67(2):218-226. PubMed ID: 26250781
[TBL] [Abstract][Full Text] [Related]
14. Association Between Midlife Obesity and Kidney Function Trajectories: The Atherosclerosis Risk in Communities (ARIC) Study.
Yu Z; Grams ME; Ndumele CE; Wagenknecht L; Boerwinkle E; North KE; Rebholz CM; Giovannucci EL; Coresh J
Am J Kidney Dis; 2021 Mar; 77(3):376-385. PubMed ID: 32979415
[TBL] [Abstract][Full Text] [Related]
15. Dietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC Study.
Rebholz CM; Coresh J; Grams ME; Steffen LM; Anderson CA; Appel LJ; Crews DC
Am J Nephrol; 2015; 42(6):427-35. PubMed ID: 26789417
[TBL] [Abstract][Full Text] [Related]
16. Urinary Fibrinogen as a Predictor of Progression of CKD.
Wang H; Zheng C; Lu Y; Jiang Q; Yin R; Zhu P; Zhou M; Liu Z
Clin J Am Soc Nephrol; 2017 Dec; 12(12):1922-1929. PubMed ID: 28903970
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
Bash LD; Erlinger TP; Coresh J; Marsh-Manzi J; Folsom AR; Astor BC
Am J Kidney Dis; 2009 Apr; 53(4):596-605. PubMed ID: 19110358
[TBL] [Abstract][Full Text] [Related]
18. Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study.
Hu EA; Selvin E; Grams ME; Steffen LM; Coresh J; Rebholz CM
Am J Kidney Dis; 2018 Aug; 72(2):214-222. PubMed ID: 29571833
[TBL] [Abstract][Full Text] [Related]
19. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death.
Elsayed EF; Sarnak MJ; Tighiouart H; Griffith JL; Kurth T; Salem DN; Levey AS; Weiner DE
Am J Kidney Dis; 2008 Jul; 52(1):29-38. PubMed ID: 18511168
[TBL] [Abstract][Full Text] [Related]
20. Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples.
Goek ON; Köttgen A; Hoogeveen RC; Ballantyne CM; Coresh J; Astor BC
Nephrol Dial Transplant; 2012 Jul; 27(7):2839-47. PubMed ID: 22287661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
